NCT00399802: A Study to Examine the Effects of an Experimental Drug on Women With Breast Cancer and Metastatic Bone Disease (MBD)(0822-016)(COMPLETED) |
|
|
| Completed | 2 | 43 | NA | ZA, Zometa®, Odanacatib, MK-0822, Odanacatib matching placebo, ZA matching placebo | Merck Sharp & Dohme LLC | Breast Cancer, Metastatic Bone Disease | 12/07 | 12/07 | | |
